the main cytologic features that can assist non-hematopathologists in recognizing lymphomas in body fluids. Methods: A retrospective review of body fluids (21 lymphomas and 21 benign fluids) at our institution from 2010 to 2015 was performed. The cytomorphologic features of lymphocytes including size (um), number of lymphocytes, neutrophils, mesothelial cells, eosinophils and histiocytes per high power field, and presence of nucleoli, hemophagocytosis, and mitosis were analyzed. Results: The size of lymphocytes in lymphoma was significantly larger (mean 5.4 um) than the control (mean 2.3 um) with P = .00003, while the number of lymphocytes was similar between the two groups (P > .6). In addition, lymphoma fluids have lower numbers of histiocytes (P = .01). Thirteen cases of lymphoma had prominent nucleoli (average number of nucleoli 1.6), which was not apparent in the control group. Hemophagocytosis was absent in both groups, and the number of neutrophils (P = .2), mesothelial cells (P = .5), eosinophils (P = .2), and mitosis (P = .3) was not significantly different between the two groups. Conclusion: Cytologic evaluation of body fluids with emphasis on size of lymphocytes is a reliable parameter for differentiating lymphoma from non-lymphoma fluids. In addition, the absence of histiocytes and presence of nucleoli in lymphocytes should alert pathologists to the possibility of lymphoma involvement. In combination with various ancillary studies, including immunocytochemistry, flow cytometry, and cytogenetics/ molecular studies, an accurate diagnosis of lymphoma can be achieved in body fluids.
Objective: Pilomatrixoma (Px) is a benign skin appendageal tumor encountered in the head, neck, and upper extremities. Its histologic features are well recognized but cytomorphologic features, especially on liquid-based preparations (LBP), and role of ancillary studies is limited. It has been potentially misdiagnosed as squamous cell carcinoma, adenocarcinoma, or small cell carcinoma. Methods: Cases of surgically proven Px from 2011 to 2016, with pre-operative cytology, were retrieved from the pathology files of NewYork Presbyterian/Weill Cornell Medical College. The samples included air-dried Diff-Quik (DQ) and alcohol stained smears (Pap), and ThinPrep (TP) and cellblock study (CB), where available.
Results: A total of 113 histologically proven cases of Px were retrieved. The mean age of the patients was 24.1 years of age (range 3 months to 70 years). The male to female ratio was 1.5:1. Only six cases had pre-operative cytology (5.4%). Of the six, four were reported as Px, including one with a concurrent core biopsy demonstrating Px, and another through ancillary testing on the cellblock. One case was reported as "suspicious for squamous cell carcinoma" based on conventional smears only, and the excision that followed demonstrated Px. The conventional smears (CS) and TP demonstrated basaloid cells and "ghost cells" in varying proportions and background cellular debris. In TP, basaloid cells were the predominant cell type, with occasional "ghost cells." Clusters of "ghost cells," and sheets of anucleate squames and giant cells were best represented on CS. Immunoreactivity to beta-catenin was compatible with Px. Conclusions: With increasing use of LBP in cytology, knowledge of the cytologic features of Px in LBP is crucial. In addition, ancillary testing on CB adds great value in diagnosing this entity.
The Diagnostic Utility of Endocervical Curettage in the Detection of Cervical Cancer and Its Precursors by Colposcopically Guided Biopsy Examinations

Ghassan Tranesh, MD, FCAP; University of California, San Diego
Objective: Endocervical curettage (ECC) specimens obtained during colposcopy can detect cervical cancer and precursors otherwise missed by biopsy alone, but the procedure can be painful and reduce compliance with needed follow-up. ECC is routinely performed in the University of California San Diego colposcopy clinics, permitting a look at its real-world utility. Study Design: We analyzed pathology and colposcopy reports from 2005 to 2015. We calculated the added diagnostic utility of ECC in normally colposcopic findings compared to cervical biopsy alone. Results: ECC increased the diagnostic yield of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in 0.98% of 18,210 colposcopically guided biopsy exams. Therefore, 210 ECC specimens were taken to detect one additional CIN2+. ECC detected 6.3% of 3,443 CIN2+ cases otherwise missed by biopsy alone. Utility was greatest among women aged 46+ referred after a high-grade cytology. Conclusions: ECC is rarely informative when used routinely in colposcopic practice. Older women referred after high-risk cytology benefit most from ECC.
